RLYBRallybio Corp

Nasdaq rallybio.com


$ 1.84 $ -0.07 (-3.68 %)    

Friday, 10-May-2024 15:59:45 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 1.83
$ 1.98
$ 0.00 x 0
$ 0.00 x 0
$ 1.82 - $ 1.99
$ 1.23 - $ 9.14
187,730
na
74.62M
$ 0.37
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-12-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-06-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-15-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 09-09-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rallybio-files-prospectus-related-to-disposition-from-time-to-time-of-up-to-36m-shares-of-common-stock-by-selling-stockholder

-SEC Filing

 hc-wainwright--co-reiterates-buy-on-rallybio-maintains-9-price-target

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Rallybio (NASDAQ:RLYB) with a Buy and maintains $9 price target.

 rallybio-q1-eps-047-beats-050-estimate

Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.50) by 6...

 jmp-securities-reiterates-market-outperform-on-rallybio-maintains-8-price-target

JMP Securities analyst Jonathan Wolleben reiterates Rallybio (NASDAQ:RLYB) with a Market Outperform and maintains $8 price t...

 jmp-securities-reiterates-market-outperform-on-rallybio-maintains-8-price-target

JMP Securities analyst Jonathan Wolleben reiterates Rallybio (NASDAQ:RLYB) with a Market Outperform and maintains $8 price t...

 rallybio-corporation-announces-fnait-systematic-literature-review-and-meta-analysis-presented-at-the-academy-of-managed-care-pharmacy-2024-annual-meeting

 - Data Support HPA-1a Negative Frequency of More than 2% in Nearly 200,000 Screened Pregnant Women -- Among HPA-1a Negative Pr...

 why-jpmorgan-shares-are-trading-lower-by-around-5-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

 benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet

The weekly Benzinga Stock Whisper Index highlights five stocks that saw increased interest from readers. Here are this week'...

 why-nextplat-shares-are-trading-higher-by-around-30-here-are-20-stocks-moving-premarket

Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023...

 nasdaq-jumps-250-points-crude-oil-down-1

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The D...

 why-fastenal-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter f...

 dow-dips-100-points-carmax-earnings-miss-views

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Thursday.

 enliven-therapeutics-alpine-immune-sciences-janux-therapeutics-and-other-big-stocks-moving-higher-on-thursday

U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NA...

 wedbush-maintains-outperform-on-rallybio-lowers-price-target-to-11

Wedbush analyst Laura Chico maintains Rallybio (NASDAQ:RLYB) with a Outperform and lowers the price target from $13 to $11.

 nasdaq-gains-over-50-points-us-producer-prices-increase-in-march

U.S. stocks traded mostly higher this morning, following the release of PPI data. Following the market opening Thursday, the D...

 rare-disease-focused-rallybio-inks-development-pact-with-johnson--johnson-stock-shoots-higher

Rallybio partners with Johnson & Johnson to develop therapies targeting fetal and neonatal alloimmune thrombocytopenia, rec...

Core News & Articles
Market-Moving News for April 11th
04/11/2024 12:31:02

RLYB: 104% | Rallybio shares are trading higher after the company announced a collaboration with Johnson & Johnson to advan...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION